Anaptysbio (ANAB) Non-Current Assets (2016 - 2026)

Anaptysbio's Non-Current Assets history runs 11 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly Non-Current Assets fell 76.97% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.5 million (down 56.64% YoY) and the FY2025 annual result came in at $14.1 million, down 72.78% from the prior year.
• Non-Current Assets was $13.6 million for Q1 2026 at Anaptysbio, down from $14.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $168.1 million in Q3 2022 and bottomed at $13.6 million in Q1 2026.
• A 5-year average of $72.7 million and a median of $58.9 million in 2025 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 1114.17% — and 2026, when it slumped 76.97%.
• Anaptysbio's Non-Current Assets stood at $163.2 million in 2022, then sank by 72.08% to $45.6 million in 2023, then grew by 14.06% to $52.0 million in 2024, then sank by 72.78% to $14.1 million in 2025, then declined by 4.03% to $13.6 million in 2026.
• Business Quant data shows ANAB's Non-Current Assets at $13.6 million in Q1 2026, $14.1 million in Q4 2025, and $22.4 million in Q3 2025.